Association between hyperglycemia and hospital length of stay in patients undergoing hematopoietic stem cell transplantation

Lindsey M. Rentschler, Sarah J. Swarts, Philip Jay Bierman, Marcel P DeVetten, Julie A. Stoner, Susan E. Puumala, Whitney S Goldner

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Patients undergoing hematopoietic stem cell transplantation (HSCT) are at high risk for hospital-related hyperglycemia due to chemotherapy, corticosteroids, and total parenteral nutrition (TPN). The prevalence of hyperglycemia and its association with complications or length of stay (LOS) is not well studied in this population.A retrospective review of 173 patients admitted for HSCT was conducted. Hospital-related hyperglycemia was consistent with American Diabetes Association criteria: 2 fasting blood glucoses 126 mg/dL or 1 blood glucose 200 mg/dL. End points were as follows: renal, cardiac, or infectious complications; graft versus host disease; LOS; and overall survival. Of the 160 patients without pre-existing diabetes, 71% were hyperglycemic. Fifty-four percent of hyperglycemic and 4% of nonhyperglycemic patients received TPN (P <0.0001). Among the 61 hyperglycemic patients given TPN, 41% developed hyperglycemia while receiving TPN. Hospital-related hyperglycemia was also associated with increased complications (56% vs. 39%, P = 0.05). Median age was higher among hyperglycemic compared with nonhyperglycemic subjects. LOS was increased among subjects who developed complications, but was not associated with development of hyperglycemia after adjustment for confounding complication and treatment variables.TPN and increasing age are both risk factors for the development of hospital-related hyperglycemia in HSCT patients. Hyperglycemia is associated with increased risk of complications but was not associated with longer LOS.

Original languageEnglish (US)
Pages (from-to)232-235
Number of pages4
JournalEndocrinologist
Volume20
Issue number5
DOIs
StatePublished - Oct 1 2010

Fingerprint

Hematopoietic Stem Cell Transplantation
Hyperglycemia
Length of Stay
Total Parenteral Nutrition
Blood Glucose
Graft vs Host Disease
Fasting
Adrenal Cortex Hormones
Kidney
Drug Therapy
Survival
Population

Keywords

  • TPN
  • hematopoietic stem cell transplant
  • hyperglycemia
  • insulin
  • intensive glycemic control

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Association between hyperglycemia and hospital length of stay in patients undergoing hematopoietic stem cell transplantation. / Rentschler, Lindsey M.; Swarts, Sarah J.; Bierman, Philip Jay; DeVetten, Marcel P; Stoner, Julie A.; Puumala, Susan E.; Goldner, Whitney S.

In: Endocrinologist, Vol. 20, No. 5, 01.10.2010, p. 232-235.

Research output: Contribution to journalArticle

@article{2ec9c7be0a7b4350a6b6f5e381ca5780,
title = "Association between hyperglycemia and hospital length of stay in patients undergoing hematopoietic stem cell transplantation",
abstract = "Patients undergoing hematopoietic stem cell transplantation (HSCT) are at high risk for hospital-related hyperglycemia due to chemotherapy, corticosteroids, and total parenteral nutrition (TPN). The prevalence of hyperglycemia and its association with complications or length of stay (LOS) is not well studied in this population.A retrospective review of 173 patients admitted for HSCT was conducted. Hospital-related hyperglycemia was consistent with American Diabetes Association criteria: 2 fasting blood glucoses 126 mg/dL or 1 blood glucose 200 mg/dL. End points were as follows: renal, cardiac, or infectious complications; graft versus host disease; LOS; and overall survival. Of the 160 patients without pre-existing diabetes, 71{\%} were hyperglycemic. Fifty-four percent of hyperglycemic and 4{\%} of nonhyperglycemic patients received TPN (P <0.0001). Among the 61 hyperglycemic patients given TPN, 41{\%} developed hyperglycemia while receiving TPN. Hospital-related hyperglycemia was also associated with increased complications (56{\%} vs. 39{\%}, P = 0.05). Median age was higher among hyperglycemic compared with nonhyperglycemic subjects. LOS was increased among subjects who developed complications, but was not associated with development of hyperglycemia after adjustment for confounding complication and treatment variables.TPN and increasing age are both risk factors for the development of hospital-related hyperglycemia in HSCT patients. Hyperglycemia is associated with increased risk of complications but was not associated with longer LOS.",
keywords = "TPN, hematopoietic stem cell transplant, hyperglycemia, insulin, intensive glycemic control",
author = "Rentschler, {Lindsey M.} and Swarts, {Sarah J.} and Bierman, {Philip Jay} and DeVetten, {Marcel P} and Stoner, {Julie A.} and Puumala, {Susan E.} and Goldner, {Whitney S}",
year = "2010",
month = "10",
day = "1",
doi = "10.1097/TEN.0b013e3181f47dbc",
language = "English (US)",
volume = "20",
pages = "232--235",
journal = "Endocrinologist",
issn = "1051-2144",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Association between hyperglycemia and hospital length of stay in patients undergoing hematopoietic stem cell transplantation

AU - Rentschler, Lindsey M.

AU - Swarts, Sarah J.

AU - Bierman, Philip Jay

AU - DeVetten, Marcel P

AU - Stoner, Julie A.

AU - Puumala, Susan E.

AU - Goldner, Whitney S

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Patients undergoing hematopoietic stem cell transplantation (HSCT) are at high risk for hospital-related hyperglycemia due to chemotherapy, corticosteroids, and total parenteral nutrition (TPN). The prevalence of hyperglycemia and its association with complications or length of stay (LOS) is not well studied in this population.A retrospective review of 173 patients admitted for HSCT was conducted. Hospital-related hyperglycemia was consistent with American Diabetes Association criteria: 2 fasting blood glucoses 126 mg/dL or 1 blood glucose 200 mg/dL. End points were as follows: renal, cardiac, or infectious complications; graft versus host disease; LOS; and overall survival. Of the 160 patients without pre-existing diabetes, 71% were hyperglycemic. Fifty-four percent of hyperglycemic and 4% of nonhyperglycemic patients received TPN (P <0.0001). Among the 61 hyperglycemic patients given TPN, 41% developed hyperglycemia while receiving TPN. Hospital-related hyperglycemia was also associated with increased complications (56% vs. 39%, P = 0.05). Median age was higher among hyperglycemic compared with nonhyperglycemic subjects. LOS was increased among subjects who developed complications, but was not associated with development of hyperglycemia after adjustment for confounding complication and treatment variables.TPN and increasing age are both risk factors for the development of hospital-related hyperglycemia in HSCT patients. Hyperglycemia is associated with increased risk of complications but was not associated with longer LOS.

AB - Patients undergoing hematopoietic stem cell transplantation (HSCT) are at high risk for hospital-related hyperglycemia due to chemotherapy, corticosteroids, and total parenteral nutrition (TPN). The prevalence of hyperglycemia and its association with complications or length of stay (LOS) is not well studied in this population.A retrospective review of 173 patients admitted for HSCT was conducted. Hospital-related hyperglycemia was consistent with American Diabetes Association criteria: 2 fasting blood glucoses 126 mg/dL or 1 blood glucose 200 mg/dL. End points were as follows: renal, cardiac, or infectious complications; graft versus host disease; LOS; and overall survival. Of the 160 patients without pre-existing diabetes, 71% were hyperglycemic. Fifty-four percent of hyperglycemic and 4% of nonhyperglycemic patients received TPN (P <0.0001). Among the 61 hyperglycemic patients given TPN, 41% developed hyperglycemia while receiving TPN. Hospital-related hyperglycemia was also associated with increased complications (56% vs. 39%, P = 0.05). Median age was higher among hyperglycemic compared with nonhyperglycemic subjects. LOS was increased among subjects who developed complications, but was not associated with development of hyperglycemia after adjustment for confounding complication and treatment variables.TPN and increasing age are both risk factors for the development of hospital-related hyperglycemia in HSCT patients. Hyperglycemia is associated with increased risk of complications but was not associated with longer LOS.

KW - TPN

KW - hematopoietic stem cell transplant

KW - hyperglycemia

KW - insulin

KW - intensive glycemic control

UR - http://www.scopus.com/inward/record.url?scp=77957571626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957571626&partnerID=8YFLogxK

U2 - 10.1097/TEN.0b013e3181f47dbc

DO - 10.1097/TEN.0b013e3181f47dbc

M3 - Article

VL - 20

SP - 232

EP - 235

JO - Endocrinologist

JF - Endocrinologist

SN - 1051-2144

IS - 5

ER -